The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis

Clinica Chimica Acta

Volumn 406, Issue 1-2, 2009, Pages 36-40

  Berneis, Kaspar ^a   Rizzo, Manfredi ^b   Spinas, Giatgen A ^a   Di Lorenzo, Gabriele ^b   Di Fede, Gaetana ^b   Pepe, Ilenia ^b   Pernice, Vincenzo ^c   Rini, Giovam Battista ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF PALERMO   (Italy)

^c Villa Maria Eleonora Hospital   (Italy)

Author keywords

Atherogenic lipoprotein phenotype; Atherosclerosis; HDL cholesterol; Small dense LDL; Triglycerides

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL AORTA ANEURYSM; ACUTE HEART INFARCTION; ADULT; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS;

AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL VASCULAR DISEASES; PHENOTYPE; RISK FACTORS;

EID: 67650302655     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.05.002     Document Type: Article

References (31)

1. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421 23
2. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine and Biology, and the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease). Circulation 113 (2006) e463-e654
3. O Neal D.N., Lewicki J., Ansari M.Z., Matthews P.G., and Best J.D. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. Atherosclerosis 136 (1998) 1-8
4. Wanhainen A., Bergqvist D., Boman K., Nilsson T.K., Rutegard J., and Bjorck M. Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg 41 (2005) 390-396
5. Berneis K., Jeanneret C., Muser J., Felix B., and Miserez A.R. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Metabolism 54 (2005) 227-234
6. Rizzo M., Pernice V., Frasheri A., and Berneis K. Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis 197 (2008) 237-241
7. Rizzo M., Krayenbühl P.A., Pernice V., Frasheri A., Rini G.B., and Berneis K. LDL size and subclasses in patients with abdominal aortic aneurysm. Int J Cardiol 134 (2009) 406-408
8. Wierzbicki A.S. Quality as well as quantity? Beyond low-density lipoprotein-cholesterol - the role of particle size. Int J Clin Pract 61 (2007) 1780-1782
9. Rizzo M., and Berneis K. Low-density-lipoproteins size and cardiovascular risk assessment QJM. Int J Med 99 (2006) 1-14
10. Austin M.A., King M.C., Vranizan K.M., and Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82 (1990) 495-506
11. Rizzo M., and Berneis K. Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention. Future Cardiol 3 (2007) 553-558
12. Allain C., Poon L., Chan C., Richmond W., and Fu P. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
13. Nagele U., Hagele E., Sauer G., Wiedemann E., Lehmann P., and Wahlefeldet A. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 22 (1984) 165-174
14. Rizzo M., Rini G.B., Spinas G., and Berneis K. A practical method to determine the "atherogenic lipoprotein phenotype". Arch Med Sci 4 (2008) 215-218
15. Grundy S.M., Cleeman J.I., Daniels S.R., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
16. Rizzo M., Berneis K., Altinova A.E., et al. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabetic Med 25 (2008) 1406-1411
17. Rizzo M., Pernice V., Frasheri A., Di Lorenzo G., Rini G.B., Spinas G.A., and Berneis K. Small, dense low-density lipoproteins are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrol (2009) 870-875
18. Krauss R., and Burke D. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23 (1982) 97-104
19. Nichols A., Krauss R., and Musliner T. Nondenaturing polyacrylamide gradient gel electrophoresis. In: Segrest J.P., and Albers J.J. (Eds). Methods in enzymology: plasma lipoproteins (1986), Academic Press, New York USA 417-431
20. Sacks F.M., and Campos H. Low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 88 (2003) 4525-4532
21. Vekic J., Topic A., Zeljkovic A., Jelic-Ivanovic Z., and Spasojevic-Kalimanovska V. LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem 40 (2007) 310-316
22. Barter P. Options for therapeutic intervention: how effective are the different agents?. Eur Heart J Suppl 8 (2006) F47-F53
23. Nesto R.W. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Am J Cardiovasc Drugs 5 (2005) 379-387
24. Lakier J.B. Smoking and cardiovascular disease. Am J Med 93 1A (1992) 8S-12S
25. Hodis H.N., and Mack W.J. Triglyceride-rich lipoproteins and progression of atherosclerosis. Eur Heart J 19 Suppl A (1998) A40-A44
26. van Tits L.J., Smilde T.J., van Wissen S., de Graaf J., Kastelein J.J., and Stalenhoef A.F. Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia. J Investig Med 52 (2004) 177-184
27. Wallenfeldt K., Bokemark L., Wikstrand J., Hulthe J., and Fagerberg B. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35 (2004) 2248-2252
28. Backes J.M., and Gibson C.A. Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein. Ann Pharmacother 39 (2005) 523-526
29. Gazi I.F., Tsimihodimos V., Tselepis A.D., Elisaf M., and Mikhailidis D.P. Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opin Biol Ther 7 (2007) 53-72
30. Feinman R.D., and Volek J.S. Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss. Nutr Metab 3 (2006) 24
31. Krauss R.M. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 25 (2005) 2265-2272